Q3 2025 Management View CEO Jean-Pierre Sommadossi reported "significant progress and achievements" this quarter, ...

If you haven’t done so already, we encourage you to determine your short- and long-term career goals to identify your postdoc training needs. Creating an IDP is a great way to do this, and when you’re ...

Faraday Copper Corp. announces its financial results for the three and nine months ended 30, 2025. Highlights Year to Date Announced initiation of the largest ever drill program at the Copper Creek ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...

Palvella’s recently expanded rare disease pipeline now comprises QTORIN™-derived product candidates advancing in four serious ...

Facility completion marks a major milestone as equipment procurement and installation begin; exploration planning accelerates ...

Evaluation: Healthcare AI must surpass accuracy metrics to establish clinical validity, safety, and suitability for diverse ...

Protests erupt in West Bengal and Jharkhand as locals fear losing livelihoods to new solar power projects at Panchet Dam.

VANCOUVER, BC / ACCESS Newswire / November 13, 2025 / Faraday Copper Corp. ("Faraday" or the "Company") (TSX:FDY) announces its financial results for the three and nine months ended September 30, 2025 ...

Hello, and thank you for joining us for i-80 Gold's 2025 Third Quarter Conference Call and Webcast. Today's company presenters include Richard Young, President and Chief Executive Officer of i-80 Gold ...